India Glycols Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
INDIAGLYCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.0 pts less than Nifty Microcap 250 and 5.2 pts less than its Breweries & Distilleries peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
India Glycols reported strong FY2026 results with standalone revenue of Rs 9,826 crore, up 8.7% from Rs 9,038 crore in FY25. PAT surged 56.5% to Rs 282 crore versus Rs 180 crore in the prior year, while EBITDA grew 32.4% to Rs 690 crore from Rs 521 crore. The auditor issued an unmodified clean opinion on both standalone and consolidated results. Key developments include a Rs 466 crore preferential share allotment completed in January 2026, ongoing demerger of Spirits & Biofuel undertaking (NCLT hearing scheduled), and interim dividend of Rs 7.50 per share declared. Bio-Fuel segment showed notable growth with revenue up 41% to Rs 1,470 crore. Operating cash flow remained strong at Rs 769 crore.
The 56% PAT growth and margin expansion indicate improving operational efficiency, which is positive for shareholders. The clean audit opinion and positive cash flows provide confidence, though the pending demerger scheme adds near-term corporate action uncertainty.